Charles River Laboratories International CRL
NYSE CRL
$282.06 +8.65 (+3.16%)
As of: Sep 17, 2026 · 3:59 PM EDT

Charles River Laboratories International (CRL) Curent Deferred Tax Liability (2010 - 2011)

Charles River Laboratories International (CRL) posted Curent Deferred Tax Liability of $1.1 million for Q3 2011, down 3.95% on a QoQ basis from $1.1 million in Q2 2011.

Analysis

Charles River Laboratories International (CRL) Curent Deferred Tax Liability (2010 - 2011) Analysis & Trends

Charles River Laboratories International has reported Curent Deferred Tax Liability for 2 years, with the latest figure at $1.1 million in Q3 2011.

  • On a quarterly basis, Curent Deferred Tax Liability changed N/A year-over-year to $1.1 million in Q3 2011; TTM through Sep 2011 was $1.1 million, a N/A change from a year earlier, with the FY2010 full-year figure at $963000.0, changed N/A from the prior year.
  • Curent Deferred Tax Liability was $1.1 million for Q3 2011 at Charles River Laboratories International, down from $1.1 million in the prior quarter.
  • The five-year high for Curent Deferred Tax Liability was $1.1 million in Q2 2011, with the low at $963000.0 in Q4 2010.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Curent Deferred Tax (Qtr)
1 Iqvia Holdings 44.72 Bn 42.64 Bn 1.44 Bn -
2 Medpace Holdings 17.37 Bn 16.87 Bn 201.64 Mn -
3 Icon 13.65 Bn 12.72 Bn 479.29 Mn -
4 Charles River Laboratories International 13.13 Bn 12.94 Bn 452.07 Mn -
5 Fortrea Holdings 1.89 Bn 1.72 Bn 139.20 Mn -
6 Evotec SE 574.75 Mn 148.87 Mn - 8.22 Mn
7 Ginkgo Bioworks Holdings 439.63 Mn 355.09 Mn 18.44 Mn -
8 Champions Oncology 69.43 Mn 65.03 Mn 7.70 Mn -
9 MindWalk Holdings 51.76 Mn 46.29 Mn 1.61 Mn -
10 VivoSim Labs 1.37 Mn 1.37 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 24, 2011 1.07 Mn
Jun 25, 2011 1.12 Mn
Dec 25, 2010 963,000.00